Log in to your Inderes Free account to see all free content on this page.
Neodynamics
0.776 SEK -12.81%HC Andersen Capital has previously received payment from Neodynamics for a Digital IR/Corporate Visibility agreement. This means that there may be paid material that is not updated. See disclaimer.
7 investors are following this company
NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of breast cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
NEOD
Daily low / high price
0.772 / 0.908
SEK
Market cap
25.31M SEK
Turnover
16.33K SEK
Volume
20K
Analyst
![Claus Thestrup Claus Thestrup](https://www.inderes.se/cdn-cgi/image/format=auto,width=128,height=128,quality=90,fit=cover/https://content.inderes.se/assets/637ef734-dcbf-426c-bf91-0ac4a79aa71e.png)
Claus Thestrup
CEO, Sweden
Latest videos
Financial calendar
Delisting
31.07.2024
Interim report
20.08.2024
Interim report
19.11.2024
Annual report
17.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Salénterprise AB | 39.9 % | 39.9 % |
Gryningskust Holding AB | 32.8 % | 32.8 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
NeoDynamics terminates the agreement with liquidity provider
NeoDynamics' stock is delisted from Nasdaq First North
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
NeoDynamics applies for delisting
Bulletin from the annual general meeting in NeoDynamics AB (publ)
Update on NeoDynamics’ financial situation
NOTICE OF ANNUAL GENERAL MEETING IN NEODYNAMICS AB (PUBL)
NeoDynamics intends to apply for delisting
NeoDynamics Interim Report Jan-March 2024
NeoDynamics publishes Annual Report 2023
Update on NeoDynamics’ management team
Salénterprise increases its shareholding in NeoDynamics.
NeoDynamics announces the final outcome regarding the exercise warrants of series TO3
Update on NeoDynamics’ Management Team
NeoDynamics announces outcome of RIghts issue of shares
![HCA Biosnack update: Biotech and Life Science stocks outperform as the general stock market moves to record highs.](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/06aef4ac-f94b-407d-ac4d-dffe67b0f7a5.png)